Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 8.57% vs -29.75% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -29.87% vs -68.64% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 34.88% vs -92.99% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 102.78% vs -52.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.24% vs -24.53% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 8.57% vs -29.75% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 50.00% vs -87.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -29.87% vs -68.64% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -74.45% vs -65.34% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 34.88% vs -92.99% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 15.87% vs 90.91% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 102.78% vs -52.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






